Wed, September 28, 2022

Corinne Jenkins Maintained (TERN) at Strong Buy with Increased Target to $9 on, Sep 28th, 2022

Corinne Jenkins of Goldman Sachs, Maintained "Terns Pharmaceuticals, Inc." (TERN) at Strong Buy with Increased Target from $4 to $9 on, Sep 28th, 2022.

Corinne has made no other calls on TERN in the last 4 months.



There is 1 other peer that has a rating on TERN. Out of the 1 peers that are also analyzing TERN, all agrees with Corinne's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Ed Arce of "HC Wainwright & Co." Initiated at Hold and Held Target at $6 on, Monday, September 12th, 2022